MERCK & CO, INC. for MERCK & CO INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2017 | $1,750,000 | Replaced |
| 3rd Quarter - Amendment | Jan 21, 2021 | $1,750,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Comprehensive tax reform (no specific bill), House Republican tax blueprint, international tax proposals (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| BRADLEY ALLEN ROSSIN | — |
Medicare/Medicaid MMM
Medicare Part D (general education, no specific bill); LIS Co-Pays (general education, no specific bill); Independent Payment Advisory Board (general education, no specific bill), Medicare Part B (general education); Medicaid (no specific bill); Antibiotics/stewardship; Vaccines for Children Fund; Hospital Outpatient Prospective Payment proposed rule (CMS); Center for Medicare and Medicaid Innovation (CMMI) demonstration
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| BRADLEY ALLEN ROSSIN | — |
Health Issues HCR
340B (no specific bill), Hepatitis C (general education; no specific bill), Vaccine policies (general education; first dollar coverage; preventative services), shingles vaccine policies (general education), antimicrobial resistance (general education), biosimilars (no specific bill), cost and value of medicines (no specific bill), women's health (general education), Affordable Care Act, general pharmaceutical issues (transparency, formulary design, prescription drug coverage), Implementation of P.L.114-255 - 21st Century Cures Act, S. 469 - Affordable and Safe Prescription Drug Importation Act, S. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| BRADLEY ALLEN ROSSIN | — |
Budget/Appropriations BUD
FY2017/FY2018, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; FY2017/FY2018, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; FY2017/FY2018, Department of Defense Appropriations; TRICARE formulary and reimbursement issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| BRADLEY ALLEN ROSSIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.